Skip to main content
Signal8

vVARDIS Holding AG (VVVV)

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Specialties

vVARDIS HOLDING AG Class A logo

vVARDIS HOLDING AG Class A

NYSE:VVVVHealthcare
-1.25%$15.80
CLOSED
AH$15.80+0.00%vs close
Mkt Cap$2.86B
EV-
Float1.69M
O/S181.09M
VOL162K sh
$ Vol$2.57M
RVOL0.10×
Inst Own-
Net Cash/Sh-
Dilution
vVARDIS HOLDING AG Class A logoNYSE:VVVVClosed$15.80-1.25%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 202615.7516.2915.6815.80161,717
Nov 16, 202616.0716.9515.9516.00676,352
Nov 13, 202614.0016.9414.0016.503,782,934
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
Zur Nieden Clifford profile photoZur Nieden CliffordGrant/Award36.5K
Stark Juergen M. profile photoStark Juergen M.Other701.8K
Stark Juergen M. profile photoStark Juergen M.Other701.8K
Stark Juergen M. profile photoStark Juergen M.Other166.3K
Stark Juergen M. profile photoStark Juergen M.Other166.3K
Rondot Thomas profile photoRondot ThomasOther733.6K
Shareholders
0.0%
Institutional
(0)
12.3%
Insiderⓘ
(5)
0.0%
5%+ Owners
(0)
87.7%
Unattributed (incl. retail)ⓘ
Insider12.3%
Unattributed (incl. retail)87.7%
Sources: Form 4O/S: 181.1M · checked 17 Nov 2026 · market-data provider
Insiders & Institutional Holders

Insiders

About

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States.

The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.

Key Metrics
Market Cap$2.86B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryMedical - Specialties
ExchangeNYSE
CountryCHCH
IPO DateNov 13, 2026
Shares Outstanding181.09M
Authorized Shares
Float1.69M
52-Week Range
Volume
Average Daily Volume1.54M
161.72K today vs 1.54M avg(-90%)

30d Avg

1.54M

60d Avg

1.54M

90d Avg

1.54M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

vVARDIS Holding AG (NYSE: VVVV) traded at $15.80 on Nov 17, 2026, down 1.25% from the previous close of $16.00. The company is in the Healthcare sector (Medical - Specialties).